Continuous Wound Catheter Analgesia Associated With Intravenous Morphine PCA After Thoracotomy

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

October 14, 2012

Primary Completion Date

October 14, 2012

Study Completion Date

October 11, 2018

Conditions
PainThoracotomy
Interventions
DRUG

ropivacaine 0.75% - device : wound catheter Silver™ 19 cm and Easypump™ 400 mL (BBraun)

The group ropivacaine, an initial bolus of 0.75% ropivacaine at a volume of 0.1 ml / kg is first administered to the patient directly on the catheter.

DRUG

Placebo

In the placebo group, an initial bolus of saline 9 ‰ to a volume of 0.1 ml / kg will first be administered to the patient directly to the catheter. The patient will then continuous administration of saline 9 ‰ during the first 48 postoperative hours, using a diffuser extensible elastomeric ™ Easypump a volume of 400 mL to 460 mL filled of this solution, a flow rate of 9.53 ml / hour.

DRUG

ropivacaine 0.2% - device : wound catheter Silver™ 19 cm and Easypump™ 400 mL (BBraun)

The patient will then ongoing administration of ropivacaine 0.2% during the first 48 postoperative hours, using a diffuser extensible elastomeric ™ Easypump a volume of 400 mL to 460 mL filled (B Braun) of this solution, a flow rate of 9.53 ml / hour

Trial Locations (1)

67091

Hôpital Civil - NHC Département d'Anesthésiologie, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT01698203 - Continuous Wound Catheter Analgesia Associated With Intravenous Morphine PCA After Thoracotomy | Biotech Hunter | Biotech Hunter